PowerShares Bio&Genome ETF

PBE-N

NYSEARCA:PBE

57.86
1.73 (2.90%)

Analysis and Opinions about PBE-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
January 31, 2011
(A Top Pick Feb 2/10. Up 19.34%.) Bio & Genome ETF. For 10 years biotech has been doing nothing but tech has been dong lots. Expects there will be a rediscovery of the space. Safe way to play the pharmacy space.
Show full opinionHide full opinion
(A Top Pick Feb 2/10. Up 19.34%.) Bio & Genome ETF. For 10 years biotech has been doing nothing but tech has been dong lots. Expects there will be a rediscovery of the space. Safe way to play the pharmacy space.
PAST TOP PICK
PAST TOP PICK
December 1, 2010
(A Top Pick Feb 2/10. Up 14.99%.) Still likes. Thinks its time is due.
Show full opinionHide full opinion
(A Top Pick Feb 2/10. Up 14.99%.) Still likes. Thinks its time is due.
TOP PICK
TOP PICK
February 2, 2010
Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.
Show full opinionHide full opinion
Bio & Genome ETF. Expect there will be massive changes in nanotechnology, stem cell research, etc. in the next 4 to 5 years. This is the only way to buy all the very small NASDAQ traded names and one of them is going to hit it rich.
BUY
BUY
September 14, 2006
This is a basket approach to biotechs and should be considered as a long-term hold. Good price.
Show full opinionHide full opinion
This is a basket approach to biotechs and should be considered as a long-term hold. Good price.
PAST TOP PICK
PAST TOP PICK
June 29, 2006
(A Top Pick Feb 23/06. Down 16%.) When the market gets nervous, speculative stocks get hit. A long-term holding because it is a basket of biotech companies. Over time, it should give investors a good long term return.
Show full opinionHide full opinion
(A Top Pick Feb 23/06. Down 16%.) When the market gets nervous, speculative stocks get hit. A long-term holding because it is a basket of biotech companies. Over time, it should give investors a good long term return.
PAST TOP PICK
PAST TOP PICK
May 8, 2006
(A Top Pick Feb 25/06. Down 6%.) A long-term hold. This is a basket of biotech shares.
Show full opinionHide full opinion
(A Top Pick Feb 25/06. Down 6%.) A long-term hold. This is a basket of biotech shares.
TOP PICK
TOP PICK
February 23, 2006
This is a way of getting into biotech without having to invest in a single company.
Show full opinionHide full opinion
This is a way of getting into biotech without having to invest in a single company.
Showing 1 to 7 of 7 entries
  • «
  • 1
  • »

PowerShares Bio&Genome ETF(PBE-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for PowerShares Bio&Genome ETF is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

PowerShares Bio&Genome ETF(PBE-N) Frequently Asked Questions

What is PowerShares Bio&Genome ETF stock symbol?

PowerShares Bio&Genome ETF is a American stock, trading under the symbol PBE-N on the NYSE Arca (PBE). It is usually referred to as AMEX:PBE or PBE-N

Is PowerShares Bio&Genome ETF a buy or a sell?

In the last year, there was no coverage of PowerShares Bio&Genome ETF published on Stockchase.

Is PowerShares Bio&Genome ETF a good investment or a top pick?

PowerShares Bio&Genome ETF was recommended as a Top Pick by Mike S. Newton, CIM FCSI on 2011-01-31. Read the latest stock experts ratings for PowerShares Bio&Genome ETF.

Why is PowerShares Bio&Genome ETF stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is PowerShares Bio&Genome ETF worth watching?

In the last year, there was no coverage of PowerShares Bio&Genome ETF published on Stockchase.

What is PowerShares Bio&Genome ETF stock price?

On 2020-10-28, PowerShares Bio&Genome ETF (PBE-N) stock closed at a price of $57.855.